Related Experiment Videos
Lethal catatonia responding to high-dose olanzapine therapy
E M Cassidy1, M O'Brien, M F Osman
1Department of Psychiatry, Royal College of Surgeons in Ireland and Beaumont Hospital, Dublin. eucass@hotmail.com
Journal of Psychopharmacology (Oxford, England)
|January 5, 2002
Summary
Lethal catatonia, a severe condition, can mimic neuroleptic malignant syndrome. High-dose olanzapine effectively treated a refractory case, highlighting its potential therapeutic role.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Bipolar disorder is a significant mental health condition.
- Refractory bipolar disorder presents treatment challenges.
- Catatonia is a complex psychomotor syndrome.
Observation:
- A 31-year-old woman with refractory bipolar disorder developed a malignant syndrome.
- The syndrome presented with catatonic motor features.
- Conventional treatments for neuroleptic malignant syndrome were ineffective.
Findings:
- The patient's lethal catatonia showed a selective response to high-dose olanzapine.
- Olanzapine treatment led to clinical improvement.
Implications:
- This case suggests lethal catatonia should be considered in non-responsive neuroleptic malignant syndrome.
- High-dose olanzapine may be a valuable treatment option for severe catatonia.
- Further research into catatonia and its treatment is warranted.